glp 1 agonists for obesity GLP-1 Receptor and Research to Treat Overeating and Substance Use Disorders Resmetirom and GLP-1 agonists for
Description
A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188
Some appeals to stay on Zepbound have been approved and other people have been able to switch to Wegovy with only mild side effects, but the change has been disruptive for many patients and their doctors
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
doi: 10.1111/dme.13595
GLP-1s are doing far more than reducing appetite
